A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants

Clinical trial NCT00418821 · TERMINATED

Trial details

NCT number: NCT00418821
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Mucopolysaccharidosis I Hurler's Syndrome Hurler-Scheie Syndrome Scheie

Start date: 2010-10-22
Primary completion: 2022-12-21
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.